Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023
Diabetes & Metabolism Journal · 01.01.2026 · 50 (1) · 127-138
DOI: 10.4093/dmj.2025.0697 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes & Metabolism Journal, erschienen am 01.01.2026. Verfasst von Hun Jee Choe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea. Hauptthemen laut MEDLINE: Obesity. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Korean Diabetes Association.
Abstract (Originalsprache)
Background
A new diagnostic framework for clinical obesity, proposed by the Lancet Commission, defines obesity as excess adiposity with organ dysfunction, offering a more functional assessment than traditional body mass index (BMI)-based classification. However, it has not been applied to Asian populations, where obesity-related complications arise at lower BMI thresholds.
Methods
We analyzed 57,863 Korean adults aged ≥20 years from the 2014 to 2023 Korea National Health and Nutrition Examination Survey (KNHANES), a nationally representative, cross-sectional dataset. Clinical obesity was defined as excess adiposity with ≥1 obesity-related complication or functional limitation; preclinical obesity was defined as excess adiposity without complications. Age, sex, and temporal trends were examined and compared with BMI-based classifications using complex sampling weights and age-standardization.
Results
The prevalence of clinical obesity and preclinical obesity was 31.2% and 8.1%, respectively. Among those with BMI-defined obesity (≥25.0 kg/m²), 20.1% had no complications, while 19.4% of overweight individuals (BMI 23.0–24.9 kg/m²) met clinical obesity criteria. Clinical obesity increased with age despite stable BMI, driven by metabolic and functional decline. Cancer prevalence was highest among individuals with clinical obesity (1.77%). Applying Western waist circumference cutoffs drastically reduced the estimated prevalence of clinical obesity to 13.1%. Longitudinal analyses showed a rising trend in clinical obesity over ime.
Conclusion
This is the first large-scale study to apply the clinical obesity framework in an Asian population. The framework identifies high-risk individuals missed by BMI al
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Hallym University Dongtan Sacred Heart Hospital, Hwaseong, Korea.
- Institute of Cardiology and Pneumology, Laval University (Institut Universitaire de Cardiologie et de Pneumologie de Québec-Université Laval), Québec, QC, Canada.
- VITAM-Research Center for Sustainable Health, Integrated University Health and Social Services Center of the Capitale-Nationale (CIUSSSCN) (VITAM- Centre de Recherche en Santé Durable, Centre Intégré Universitaire de Sa…
- Department of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
- Pennington Biomedical Research Center, Baton Rouge, LA, USA.
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
Förderung
- Korean Diabetes Association
Zitieren
APA
Choe, H. J., Després, J. P., Wilding, J. P. H., Ryan, D. H., & Lim, S. (2026). Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023. Diabetes & Metabolism Journal, 50(1), 127-138. https://doi.org/10.4093/dmj.2025.0697
Vancouver
Choe HJ, Després JP, Wilding JPH, Ryan DH, Lim S. Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023. Diabetes & Metabolism Journal. 2026;50(1):127-138. doi:10.4093/dmj.2025.0697
BibTeX
@article{Choe2026,
author = {Choe, Hun Jee and Després, Jean-Pierre and Wilding, John P H and Ryan, Donna H and Lim, Soo},
title = {Clinical and Preclinical Obesity in Korean Adults from 2014 to 2023},
journal = {Diabetes & Metabolism Journal},
year = {2026},
volume = {50},
number = {1},
pages = {127--138},
doi = {10.4093/dmj.2025.0697}
}
EUVIMED